{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:07:30Z","timestamp":1793956050792,"version":"4.8.0"},"reference-count":60,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["308431\/2017-0-CNPq-BR"],"award-info":[{"award-number":["308431\/2017-0-CNPq-BR"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["409146\/2018-8-CNPq-BR"],"award-info":[{"award-number":["409146\/2018-8-CNPq-BR"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["465536\/2014-0-CNPq-BR"],"award-info":[{"award-number":["465536\/2014-0-CNPq-BR"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003401","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Alagoas","doi-asserted-by":"publisher","award":["EFP_00007992-PPSUS\/FAPEAL-BR"],"award-info":[{"award-number":["EFP_00007992-PPSUS\/FAPEAL-BR"]}],"id":[{"id":"10.13039\/501100003401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> Leishmaniasis is a worldwide health problem, highly endemic in developing countries. Among the four main clinical forms of the disease, visceral leishmaniasis is the most severe, fatal in 95% of cases. The undesired side-effects from first-line chemotherapy and the reported drug resistance search for effective drugs that can replace or supplement those currently used an urgent need. Aminoguanidine hydrazones (AGH's) have been explored for exhibiting a diverse spectrum of biological activities, in particular the antileishmanial activity of MGBG. The bioisosteres thiosemicarbazones (TSC's) offer a similar biological activity diversity, including antiprotozoal effects against Leishmania species and Trypanosoma cruzi. <\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>Considering the impact of leishmaniasis worldwide, this work aimed to design, synthesize, and perform a screening upon L. chagasi amastigotes and for the cytotoxicity of the small \"in-house\" library of both AGH and TSC derivatives and their structurally-related compounds.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Method:<\/jats:title>\n<jats:p>A set of AGH's (3-7), TSC's (9, 10), and semicarbazones (11) were initially synthesized. Subsequently, different semi-constrained analogs were designed and also prepared, including thiazolidines (12), dihydrothiazines (13), imidazolines (15), pyrimidines (16, 18) azines (19, 20), and benzotriazepinones (23-25). All intermediates and target compounds were obtained with satisfactory yields and exhibited spectral data consistent with their structures. All final compounds were evaluated against L. chagasi amastigotes and J774.A1 cell line. Molecular docking was performed towards trypanothione reductase using GOLD\u00ae software. <\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Result:<\/jats:title>\n<jats:p>The AGH's 3i, 4a, and 5d, and the TSC's 9i, 9k, and 9o were selected as valuable hits. These compounds presented antileishmanial activity compared with pentamidine, showing IC50 values ranged from 0.6 to 7.27 \u03bcM, maximal effects up to 55.3%, and satisfactory SI values (ranged from 11 to 87). On the other hand, most of the resulting semi-constrained analogs were found cytotoxic or presented reduced antileishmanial activity. In general, TSC class is more promising than its isosteric AGH analogs, and the beneficial aromatic substituent effects are not similar in both series. In silico studies have suggested that these hits are capable of inhibiting the trypanothione reductase from the amastigote forms. <\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The promising antileishmanial activity of three AGH\u2019s and three TSC\u2019s was characterized. These compounds presented antileishmanial activity compared with PTD, showing IC50 values ranged from 0.6 to 7.27 \u03bcM, and satisfactory SI values. Further pharmacological assays involving other Leishmania strains are under progress, which will help to choose the best hits for in vivo experiments.\n<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573406417666210216154428","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T11:37:08Z","timestamp":1613561828000},"page":"151-169","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Synthesis, Antileishmanial Activity and in silico Studies of Aminoguanidine Hydrazones (AGH) and Thiosemicarbazones (TSC) Against Leishmania chagasi Amastigotes"],"prefix":"10.2174","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9138-8466","authenticated-orcid":true,"given":"Thiago M.","family":"de Aquino","sequence":"first","affiliation":[{"name":"Laboratory of Medicinal Chemistry, Institute of Pharmaceutical Sciences, Federal University of Alagoas, Macei\u00f3-AL 57072-900, Brazil | Institute of Chemistry and Biotechnology, Federal University of Alagoas, 57072-900, Macei\u00f3-AL, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2464-3273","authenticated-orcid":true,"given":"Paulo H. B.","family":"Fran\u00e7a","sequence":"additional","affiliation":[{"name":"Laboratory of Medicinal Chemistry, Institute of Pharmaceutical Sciences, Federal University of Alagoas, Macei\u00f3-AL 57072-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7069-6478","authenticated-orcid":true,"given":"\u00c9rica E. E. S.","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Laboratory of Medicinal Chemistry, Institute of Pharmaceutical Sciences, Federal University of Alagoas, Macei\u00f3-AL 57072-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2664-4336","authenticated-orcid":true,"given":"Igor. J.S.","family":"Nascimento","sequence":"additional","affiliation":[{"name":"Laboratory of Medicinal Chemistry, Institute of Pharmaceutical Sciences, Federal University of Alagoas, Macei\u00f3-AL 57072-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7626-5238","authenticated-orcid":true,"given":"Paulo F. S.","family":"Santos-J\u00fanior","sequence":"additional","affiliation":[{"name":"Laboratory of Medicinal Chemistry, Institute of Pharmaceutical Sciences, Federal University of Alagoas, Macei\u00f3-AL 57072-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8826-1683","authenticated-orcid":true,"given":"Pedro G. V.","family":"Aquino","sequence":"additional","affiliation":[{"name":"Chemistry Institute, Federal\nRural University of Pernambuco, Garanhuns-PE 55292-270, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4346-8282","authenticated-orcid":true,"given":"Mariana S.","family":"Santos","sequence":"additional","affiliation":[{"name":"Chemistry Institute, Federal\nRural University of Pernambuco, Garanhuns-PE 55292-270, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6362-2726","authenticated-orcid":true,"given":"Aline C.","family":"Queiroz","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology and Immunology, Institute of Biological\nand Health Sciences, Federal University of Alagoas, Macei\u00f3-AL 57072-900, Brazil | Laboratory of Microbiology, Immunology and\nParasitology, Medical Science Center, Campus Arapiraca, Federal University of Alagoas, Arapiraca-AL 57309-005, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9042-7507","authenticated-orcid":true,"given":"Morgana V.","family":"Ara\u00fajo","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology and Immunology, Institute of Biological\nand Health Sciences, Federal University of Alagoas, Macei\u00f3-AL 57072-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magna S.","family":"Alexandre-Moreira","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology and Immunology, Institute of Biological\nand Health Sciences, Federal University of Alagoas, Macei\u00f3-AL 57072-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6422-7798","authenticated-orcid":true,"given":"Raiza R. L.","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Laboratory\nof Infectious Diseases, Federal University of Parna\u00edba Delta, Parna\u00edba-PI 64202-020, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3904-3529","authenticated-orcid":true,"given":"Klinger A. F.","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Laboratory of Infectious Diseases, Federal University of Parna\u00edba Delta, Parna\u00edba-PI 64202-020, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6977-3322","authenticated-orcid":true,"given":"Johnnatan D.","family":"Freitas","sequence":"additional","affiliation":[{"name":"Instrumental Analysis Laboratory, Federal\nInstitute of Alagoas, Campus Macei\u00f3, Ferrovi\u00e1rio Avenue, Macei\u00f3-AL 57020-600, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7268-4534","authenticated-orcid":true,"given":"Jacques","family":"Bricard","sequence":"additional","affiliation":[{"name":"Laboratoire d\\'Innovation th\u00e9rapeutique,\nLabex Medalis, UMR 7200, CNRS, Facult\u00e9 de Pharmacie, Universit\u00e9 de Strasbourg, 74 route du Rhin, BP 60024, Illkirch 67401, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0722-8599","authenticated-orcid":true,"given":"Mario R.","family":"Meneghetti","sequence":"additional","affiliation":[{"name":"Institute of Chemistry and Biotechnology, Federal University of Alagoas, 57072-900, Macei\u00f3-AL, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2021-938X","authenticated-orcid":true,"given":"Jean-Jacques","family":"Bourguignon","sequence":"additional","affiliation":[{"name":"Laboratoire d\\'Innovation th\u00e9rapeutique,\nLabex Medalis, UMR 7200, CNRS, Facult\u00e9 de Pharmacie, Universit\u00e9 de Strasbourg, 74 route du Rhin, BP 60024, Illkirch 67401, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8723-9502","authenticated-orcid":true,"given":"Martine","family":"Schmitt","sequence":"additional","affiliation":[{"name":"Laboratoire d\\'Innovation th\u00e9rapeutique,\nLabex Medalis, UMR 7200, CNRS, Facult\u00e9 de Pharmacie, Universit\u00e9 de Strasbourg, 74 route du Rhin, BP 60024, Illkirch 67401, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1527-4501","authenticated-orcid":true,"given":"Edeildo F.","family":"da Silva-J\u00fanior","sequence":"additional","affiliation":[{"name":"Laboratory of Medicinal Chemistry, Institute of Pharmaceutical Sciences, Federal University of Alagoas, Macei\u00f3-AL 57072-900, Brazil | Institute of Chemistry and Biotechnology, Federal University of Alagoas, 57072-900, Macei\u00f3-AL, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3187-183X","authenticated-orcid":true,"given":"Jo\u00e3o X.","family":"de Ara\u00fajo-J\u00fanior","sequence":"additional","affiliation":[{"name":"Laboratory of Medicinal Chemistry, Institute of Pharmaceutical Sciences, Federal University of Alagoas, Macei\u00f3-AL 57072-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.actatropica.2016.12.013","volume":"168","author":"Yaluff G.","year":"2017","unstructured":"Yaluff G.; Vega C.; Alvarenga N.; In vitro antiprotozoal activity of (S)-cis-Verbenol against Leishmania spp. and Trypanosoma cruzi. Acta Trop 2017,168,41-44","journal-title":"Acta Trop"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.actatropica.2017.04.022","volume":"172","author":"Foroutan M.","year":"2017","unstructured":"Foroutan M.; Khademvatan S.; Majidiani H.; Khalkhali H.; Hedayati-Rad F.; Khashaveh S.; Mohammadzadeh H.; Prevalence of Leishmania species in rodents: A systematic review and meta-analysis in Iran. Acta Trop 2017,172,164-172","journal-title":"Acta Trop"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejmech.2014.07.092","volume":"85","author":"Kryshchyshyn A.","year":"2014","unstructured":"Kryshchyshyn A.; Kaminskyy D.; Grellier P.; Lesyk R.; Trends in research of antitrypanosomal agents among synthetic heterocycles. Eur J Med Chem 2014,85,51-64","journal-title":"Eur J Med Chem"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1016\/j.bmc.2016.07.013","volume":"24","author":"Silva-J&#xFA;nior E.F.","year":"2016","unstructured":"Silva-J&#xFA;nior E.F.; Silva E.P.S.; Fran&#xE7;a P.H.B.; Silva J.P.N.; Barreto E.O.; Silva E.B.; Ferreira R.S.; Gatto C.C.; Moreira D.R.M.; Siqueira-Neto J.L.; Mendon&#xE7;a-J&#xFA;nior F.J.B.; Lima M.C.A.; Bortoluzzi J.H.; Scotti M.T.; Scotti L.; Meneghetti M.R.; Aquino T.M.; Ara&#xFA;jo-J&#xFA;nior J.X.; Design, synthesis, molecular docking and biological evaluation of thiophen-2-iminothiazolidine derivatives for use against Trypanosoma cruzi. Bioorg Med Chem 2016,24(18),4228-4240","journal-title":"Bioorg Med Chem"},{"key":"ref=5","unstructured":"WHO. Leishmaniasis. Available from: https:\/\/www.who.int\/health-topics\/leishmaniasis#tab=tab_1"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ejmech.2016.07.014","volume":"123","author":"Manzano J.I.","year":"2016","unstructured":"Manzano J.I.; Cochet F.; Boucherle B.; G&#xF3;mez-P&#xE9;rez V.; Boumendjel A.; Gamarro F.; Peuchmaur M.; Arylthiosemicarbazones as antileishmanial agents. Eur J Med Chem 2016,123,161-170","journal-title":"Eur J Med Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.actatropica.2016.11.013","volume":"166","author":"Metzdorf I.P.","year":"2017","unstructured":"Metzdorf I.P.; da Costa Lima M.S.; de Fatima Cepa Matos M.; de Souza Filho A.F.; de Souza Tsujisaki R.A.; Franco K.G.; Shapiro J.T.; de Almeida Borges F.; Molecular characterization of Leishmania infantum in domestic cats in a region of Brazil endemic for human and canine visceral leishmaniasis. Acta Trop 2017,166,121-125","journal-title":"Acta Trop"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.exppara.2017.02.005","volume":"175","author":"Veiga A.","year":"2017","unstructured":"Veiga A.; Albuquerque K.; Corr&#xEA;a M.E.; Brigido H.; Silva E.; Silva, J.; Campos, M.; Silveira, F.; Santos, L.; Dolabela, M. Leishmania amazonensis and Leishmania chagasi: In vitro leishmanicide activity of Virola surinamensis (rol.) warb. Exp Parasitol 2017,175,68-73","journal-title":"Exp Parasitol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.5858\/arpa.2013-0098-OA","volume":"138","author":"Shirian S.","year":"2014","unstructured":"Shirian S.; Oryan A.; Hatam G-R.; Panahi S.; Daneshbod Y.; Comparison of conventional, molecular, and immunohistochemical methods in diagnosis of typical and atypical cutaneous leishmaniasis. Arch Pathol Lab Med 2014,138(2),235-240","journal-title":"Arch Pathol Lab Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.tmaid.2013.09.001","volume":"12","author":"Shafiei R.","year":"2014","unstructured":"Shafiei R.; Mohebali M.; Akhoundi B.; Galian M.S.; Kalantar F.; Ashkan S.; Fata A.; Farash B.R.; Ghasemian M.; Emergence of co-infection of visceral leishmaniasis in HIV-positive patients in northeast Iran: a preliminary study. Travel Med Infect Dis 2014,12(2),173-178","journal-title":"Travel Med Infect Dis"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.pt.2016.11.003","volume":"33","author":"Hefnawy A.","year":"2017","unstructured":"Hefnawy A.; Berg M.; Dujardin J-C.; De Muylder G.; Exploiting Knowledge on Leishmania Drug Resistance to Support the Quest for New Drugs. Trends Parasitol 2017,33(3),162-174","journal-title":"Trends Parasitol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.actatropica.2017.01.005","volume":"169","author":"Abamor E.S.","year":"2017","unstructured":"Abamor E.S.; Allahverdiyev A.M.; Bagirova M.; Rafailovich M.; Meglumine ant\u0131moniate-TiO2@Ag nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect. Acta Trop 2017,169,30-42","journal-title":"Acta Trop"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ejmech.2015.09.009","volume":"103","author":"de Melos J.L.R.","year":"2015","unstructured":"de Melos J.L.R.; Torres-Santos E.C.; Fai&#xF5;es V. dos S.; Del Cistia, Cde.N.; Sant\u2019Anna, C.M.; Rodrigues-Santos, C.E.; Echevarria, A. Novel 3,4-methylenedioxyde-6-X-benzaldehyde-thiosemicarbazones: Synthesis and antileishmanial effects against Leishmania amazonensis. Eur J Med Chem 2015,103,409-417","journal-title":"Eur J Med Chem"},{"key":"ref=14","unstructured":"WHO. Accelerated Plan for Kala-Azar Elimination - Directorate National Vector Borne Disease Control Programme. 2017. Available from: https:\/\/www.who.int\/leishmaniasis\/resources\/Accelerated_plan_for_Kala-azar_Elimination_2017\/en\/"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.actatropica.2017.04.029","volume":"172","author":"Akbari M.","year":"2017","unstructured":"Akbari M.; Oryan A.; Hatam G.; Application of nanotechnology in treatment of leishmaniasis: A Review. Acta Trop 2017,172,86-90","journal-title":"Acta Trop"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.molbiopara.2008.12.012","volume":"165","author":"Rochette A.","year":"2009","unstructured":"Rochette A.; Raymond F.; Corbeil J.; Ouellette M.; Papadopoulou B.; Whole-genome comparative RNA expression profiling of axenic and intracellular amastigote forms of Leishmania infantum. Mol Biochem Parasitol 2009,165(1),32-47","journal-title":"Mol Biochem Parasitol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.actatropica.2016.08.020","volume":"165","author":"Shokri A.","year":"2017","unstructured":"Shokri A.; Fakhar M.; Teshnizi S.H.; Canine visceral leishmaniasis in Iran: A systematic review and meta-analysis. Acta Trop 2017,165,76-89","journal-title":"Acta Trop"},{"key":"ref=18","first-page":"345","volume":"123","author":"Sundar S.","year":"2006","unstructured":"Sundar S.; Chatterjee M.; Visceral Leishmaniasis - current therapeutic modalities. Indian J Med Res 2006,123(3),345-352","journal-title":"Indian J Med Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00436-010-2230-2","volume":"108","author":"Shakya N.","year":"2011","unstructured":"Shakya N.; Sane S.A.; Gupta S.; Antileishmanial efficacy of fluconazole and miltefosine in combination with an immunomodulator--picroliv. Parasitol Res 2011,108(4),793-800","journal-title":"Parasitol Res"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"8771","DOI":"10.1038\/srep08771","volume":"5","author":"Pe&#xF1;a I.","year":"2015","unstructured":"Pe&#xF1;a I.; Pilar Manzano M.; Cantizani J.; Kessler A.; Alonso-Padilla J.; Bardera A.I.; Alvarez E.; Colmenarejo G.; Cotillo I.; Roquero I.; de Dios-Anton F.; Barroso V.; Rodriguez A.; Gray D.W.; Navarro M.; Kumar V.; Sherstnev A.; Drewry D.H.; Brown J.R.; Fiandor J.M.; Julio Martin J.; New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource. Sci Rep 2015,5,8771","journal-title":"Sci Rep"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nature19339","volume":"537","author":"Khare S.","year":"2016","unstructured":"Khare S.; Nagle A.S.; Biggart A.; Lai Y.H.; Liang F.; Davis L.C.; Barnes S.W.; Mathison C.J.N.; Myburgh E.; Gao M-Y.; Gillespie J.R.; Liu X.; Tan J.L.; Stinson M.; Rivera I.C.; Ballard J.; Yeh V.; Groessl T.; Federe G.; Koh H.X.Y.; Venable J.D.; Bursulaya B.; Shapiro M.; Mishra P.K.; Spraggon G.; Brock A.; Mottram J.C.; Buckner F.S.; Rao S.P.S.; Wen B.G.; Walker J.R.; Tuntland T.; Molteni V.; Glynne R.J.; Supek F.; Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness. Nature 2016,537(7619),229-233","journal-title":"Nature"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.exppara.2017.04.003","volume":"177","author":"da Silva A.C.","year":"2017","unstructured":"da Silva A.C.; Dos Santos T.A.R.; da Silva I.V.B.; de Oliveira M.V.G.; Moreira D.R.M.; Leite A.C.L.; Pereira V.R.A.; Aryl thiosemicarbazones: In vitro and immunomodulatory activities against L. amazonensis. Exp Parasitol 2017,177,57-65","journal-title":"Exp Parasitol"},{"key":"ref=23","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6813467","volume":"2018","author":"Ch&#xE1;vez-Fumagalli M.A.","year":"2018","unstructured":"Ch&#xE1;vez-Fumagalli M.A.; Schneider M.S.; Lage D.P.; Tavares G.S.V.; Mendon&#xE7;a D.V.C.; Santos T.T.O.; P&#xE1;dua R.M.; Machado-de-&#xC1;vila R.A.; Leite J.P.V.; Coelho E.A.F.; A computational approach using bioinformatics to screening drug targets for Leishmania infantum species. Evid Based Complement Alternat Med 2018,2018","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1515\/acph-2016-0015","volume":"66","author":"Fran&#xE7;a P.H.B.","year":"2016","unstructured":"Fran&#xE7;a P.H.B.; Da Silva-J&#xFA;nior E.F.; Aquino P.G.V.; Santana A.E.G.; Ferro J.N.S.; De Oliveira Barreto E.; Do &#xD3; Pessoa C.; Meira A.S.; De Aquino T.M.; Alexandre-Moreira M.S.; Schmitt M.; De Ara&#xFA;jo-J&#xFA;nior J.X.; Preliminary in vitro evaluation of the anti-proliferative activity of guanylhydrazone derivatives. Acta Pharm 2016,66(1),129-137","journal-title":"Acta Pharm"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1021\/cr9603845","volume":"97","author":"Schmidtchen F.P.","year":"1997","unstructured":"Schmidtchen F.P.; Berger M.; Artificial organic host molecules for anions. Chem Rev 1997,97(5),1609-1646","journal-title":"Chem Rev"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/S0960-894X(03)00347-0","volume":"13","author":"Lange U.E.","year":"2003","unstructured":"Lange U.E.; Baucke D.; Hornberger W.; Mack H.; Seitz W.; H&#xF6;ffken H.W.; D-Phe-Pro-Arg type thrombin inhibitors: unexpected selectivity by modification of the P1 moiety. Bioorg Med Chem Lett 2003,13(12),2029-2033","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1021\/jm00163a049","volume":"33","author":"Sundberg R.J.","year":"1990","unstructured":"Sundberg R.J.; Dahlhausen D.J.; Manikumar G.; Mavunkel B.; Biswas A.; Srinivasan V.; Musallam H.A.; Reid W.A.; Ager A.L.; Cationic antiprotozoal drugs. Trypanocidal activity of 2-(4\u2032-formylphenyl)imidazo[1,2-a]pyridinium guanylhydrazones and related derivatives of quaternary heteroaromatic compounds. J Med Chem 1990,33(1),298-307","journal-title":"J Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/0014-4894(79)90131-0","volume":"48","author":"Bachrach U.","year":"1979","unstructured":"Bachrach U.; Brem S.; Wertman S.B.; Schnur L.F.; Greenblatt C.L.; Leishmania spp.: effect of inhibitors on growth and on polyamine and macromolecular syntheses. Exp Parasitol 1979,48(3),464-470","journal-title":"Exp Parasitol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"5902","DOI":"10.1074\/jbc.M110118200","volume":"277","author":"Roberts S.C.","year":"2002","unstructured":"Roberts S.C.; Scott J.; Gasteier J.E.; Jiang Y.; Brooks B.; Jardim A.; Carter N.S.; Heby O.; Ullman B.; S-adenosylmethionine decarboxylase from Leishmania donovani. Molecular, genetic, and biochemical characterization of null mutants and overproducers. J Biol Chem 2002,277(8),5902-5909","journal-title":"J Biol Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/1357-2725(95)93432-P","volume":"27","author":"Mukhopadhyay R.","year":"1995","unstructured":"Mukhopadhyay R.; Madhubala R.; Antileishmanial activity of berenil and methylglyoxal bis (guanylhydrazone) and its correlation with S-adenosylmethionine decarboxylase and polyamines. Int J Biochem Cell Biol 1995,27(1),55-59","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1016\/j.bmcl.2006.05.041","volume":"16","author":"Siles R.","year":"2006","unstructured":"Siles R.; Chen S.E.; Zhou M.; Pinney K.G.; Trawick M.L.; Design, synthesis, and biochemical evaluation of novel cruzain inhibitors with potential application in the treatment of Chagas\u2019 disease. Bioorg Med Chem Lett 2006,16(16),4405-4409","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1021\/jm010459j","volume":"45","author":"Du X.","year":"2002","unstructured":"Du X.; Guo C.; Hansell E.; Doyle P.S.; Caffrey C.R.; Holler T.P.; McKerrow J.H.; Cohen F.E.; Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain. J Med Chem 2002,45(13),2695-2707","journal-title":"J Med Chem"},{"key":"ref=33","author":"Fred C.E.","year":"2005","unstructured":"Fred C.E.; Xiaohui D.; Chun G.; James M.H.;  hio semicarbazone\nand semicarbozone inhibitors of cysteine proteases and methods\nof their use US7495023, 2005","journal-title":"hio semicarbazone\nand semicarbozone inhibitors of cysteine proteases and methods\nof their use US7495023,"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ejmech.2012.07.013","volume":"55","author":"Caputto M.E.","year":"2012","unstructured":"Caputto M.E.; Ciccarelli A.; Frank F.; Moglioni A.G.; Moltrasio G.Y.; Vega D.; Lombardo E.; Finkielsztein L.M.; Synthesis and biological evaluation of some novel 1-indanone thiazolylhydrazone derivatives as anti-Trypanosoma cruzi agents. Eur J Med Chem 2012,55,155-163","journal-title":"Eur J Med Chem"},{"key":"ref=35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077460","volume":"8","author":"Schr&#xF6;der J.","year":"2013","unstructured":"Schr&#xF6;der J.; Noack S.; Marh&#xF6;fer R.J.; Mottram J.C.; Coombs G.H.; Selzer P.M.; Identification of semicarbazones, thiosemicarbazones and triazine nitriles as inhibitors of Leishmania mexicana cysteine protease CPB. PLoS One 2013,8(10)","journal-title":"PLoS One"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12866-014-0236-0","volume":"14","author":"Britta E.A.","year":"2014","unstructured":"Britta E.A.; Scariot D.B.; Falzirolli H.; Ueda-Nakamura T.; Silva C.C.; Filho B.P.D.; Borsali R.; Nakamura C.V.; Cell death and ultrastructural alterations in Leishmania amazonensis caused by new compound 4-Nitrobenzaldehyde thiosemicarbazone derived from S-limonene. BMC Microbiol 2014,14,236","journal-title":"BMC Microbiol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1017\/S0031182015000141","volume":"142","author":"Britta E.A.","year":"2015","unstructured":"Britta E.A.; Scariot D.B.; Falzirolli H.; da Silva C.C.; Ueda-Nakamura T.; Dias Filho B.P.; Borsali R.; Nakamura C.V.; 4-Nitrobenzaldehyde thiosemicarbazone: a new compound derived from S-(-)-limonene that induces mitochondrial alterations in epimastigotes and trypomastigotes of Trypanosoma cruzi. Parasitology 2015,142(7),978-988","journal-title":"Parasitology"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"Mosmann T.","year":"1983","unstructured":"Mosmann T.; Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983,65(1-2),55-63","journal-title":"J Immunol Methods"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0022-1759(93)90012-V","volume":"160","author":"Hussain R.F.","year":"1993","unstructured":"Hussain R.F.; Nouri A.M.E.; Oliver R.T.D.; A new approach for measurement of cytotoxicity using colorimetric assay. J Immunol Methods 1993,160(1),89-96","journal-title":"J Immunol Methods"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.micinf.2004.08.022","volume":"7","author":"Nunes M.P.","year":"2005","unstructured":"Nunes M.P.; Cysne-Finkelstein L.; Monteiro B.C.; de Souza D.M.; Gomes N.A.; DosReis G.A.; CD40 signaling induces reciprocal outcomes in Leishmania-infected macrophages; roles of host genotype and cytokine milieu. Microbes Infect 2005,7(1),78-85","journal-title":"Microbes Infect"},{"key":"ref=41","author":"Thompson M.","unstructured":"Thompson M.;  ArgusLab 2004 Available from:  http:\/\/www.arguslab.com","journal-title":"ArgusLab 2004 Available from:"},{"key":"ref=42","first-page":"1","year":"2015","unstructured":"GOLD User Guide A Component of the GOLD Suite Cambridge Crystallographic Data Centre.2015,1-235","journal-title":"GOLD User Guide A Component of the GOLD Suite"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.bios.2019.02.071","volume":"133","author":"Lozano Untiveros K.","year":"2019","unstructured":"Lozano Untiveros K.; da Silva E.G.; de Abreu F.C.; da Silva-J&#xFA;nior E.F.; de Ara&#xFA;jo-Junior J.X.; Mendo&#xE7;a de Aquino T.; Armas S.M.; de Moura R.O.; Mendon&#xE7;a-Junior F.J.B.; Serafim V.L.; Chumbimuni-Torres K.; An electrochemical biosensor based on Hairpin-DNA modified gold electrode for detection of DNA damage by a hybrid cancer drug intercalation. Biosens Bioelectron 2019,133,160-168","journal-title":"Biosens Bioelectron"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bioorg.2019.03.030","volume":"87","author":"Santana C.C.","year":"2019","unstructured":"Santana C.C.; Silva-J&#xFA;nior E.F.; Santos J.C.N.; Rodrigues &#xC9;.E.D.S.; da Silva I.M.; Ara&#xFA;jo-J&#xFA;nior J.X.; do Nascimento T.G.; Oliveira Barbosa L.A.; Dornelas C.B.; Figueiredo I.M.; Santos J.C.C.; Grillo L.A.M.; Evaluation of guanylhydrazone derivatives as inhibitors of Candida rugosa digestive lipase: Biological, biophysical, theoretical studies and biotechnological application. Bioorg Chem 2019,87,169-180","journal-title":"Bioorg Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.2174\/1568026619666190621120304","volume":"19","author":"Roque Marques K.M.","year":"2019","unstructured":"Roque Marques K.M.; do Desterro M.R.; de Arruda S.M.; de Ara&#xFA;jo Neto L.N.; do Carmo Alves de Lima M.; de Almeida S.M.V.; da Silva E.C.D.; de Aquino T.M.; da Silva-J&#xFA;nior E.F.; de Ara&#xFA;jo-J&#xFA;nior J.X.; de M Silva, M.; de A Dantas, M.D.; Santos, J.C.C.; Figueiredo, I.M.; Bazin, M.A.; Marchand, P.; da Silva, T.G.; Mendon&#xE7;a Junior, F.J.B. 5-Nitro-thiophene-thiosemicarbazone derivatives present antitumor activity mediated by apoptosis and DNA intercalation. Curr Top Med Chem 2019,19(13),1075-1091","journal-title":"Curr Top Med Chem"},{"key":"ref=46","author":"Marques R.A.","unstructured":"Marques R.A.; Gomes A.O.C.V.; de Brito M.V.; dos Santos A.L.P.; da Silva G.S.; de Lima L.B.; Nunes F.M.; de Mattos M.C.; de Oliveira F.C.E.; do &#xD3; Pessoa C.; de Moraes M.O.; de F&#xE1;tima &#xC2;.; Franco L.L.; Silva M.D.M.; Dantas M.D.D.A.; Santos J.C.C.; Figueiredo I.M.; da Silva-J&#xFA;nior E.F.; de Aquino T.M.; de Ara&#xFA;jo-J&#xFA;nior J.X.; de Oliveira M.C.F.; Leslie Gunatilaka A.A.;  Annonalide and derivatives: semisynthesis, cytotoxic activities\nand studies on interaction of annonalide with DNA J Photochem\nPhotobiol B Biol, 2018, 179","journal-title":"Annonalide and derivatives: semisynthesis, cytotoxic activities\nand studies on interaction of annonalide with DNA J Photochem\nPhotobiol B Biol, 2018, 179"},{"key":"ref=47","first-page":"165","volume":"189","year":"2018","unstructured":"B Biol de M. Silva, M.; Macedo, T.S.; Teixeira, H.M.P.; Moreira, D.R.M.; Soares, M.B.P.; da C. Pereira, A.L.; de L. Serafim, V.; Mendon&#xE7;a-J&#xFA;nior, F.J.B.; do Carmo A. de Lima, M.; de Moura, R.O.; da Silva-J&#xFA;nior, E.F.; de Ara&#xFA;jo-J&#xFA;nior, J.X.; de A. Dantas, M.D.; de O. O. Nascimento, E.; Maciel, T.M.S.; de Aquino, T.M.; Figueiredo, I.M.; Santos, J.C.C. Correlation between DNA\/HSA-interactions and antimalarial activity of acridine derivatives: proposing a possible mechanism of action. J. Photochem. Photobiol.2018,189,165-175","journal-title":"B Biol"},{"key":"ref=48","first-page":"68","volume":"14","author":"da Silva-Junior E.F.","year":"2017","unstructured":"da Silva-Junior E.F.; Barcellos Franca P.H.; Ribeiro F.F.; Bezerra Mendonca-Junior F.J.; Scotti L.; Scotti M.T.; de Aquino T.M.; de Araujo-Junior J.X.; Molecular Docking Studies Applied to a Dataset of Cruzain Inhibitors. Curr. Comput. Aided. Drug Des 2017,14,68-78","journal-title":"Drug Des"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"266","DOI":"10.2174\/1573409913666170406150905","volume":"13","author":"Silva-Junior E.F.","year":"2017","unstructured":"Silva-Junior E.F.; Barcellos Franca P.H.; Quintans-Junior L.J.; Mendonca-Junior F.J.B.; Scotti L.; Scotti M.T.; de Aquino T.M.; de Araujo-Junior J.X.; Dynamic simulation, docking and DFT studies applied to a set of anti-acetylcholinesterase inhibitors in the enzyme &#x3B2;-secretase (BACE-1): An important therapeutic target in Alzheimer\u2019s disease. Curr Comput Aided Drug Des 2017,13(4),266-274","journal-title":"Curr Comput Aided Drug Des"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cbi.2017.12.009","volume":"280","author":"Dantas N.","year":"2018","unstructured":"Dantas N.; de Aquino T.M.; de Ara&#xFA;jo-J&#xFA;nior J.X.; da Silva-J&#xFA;nior E.; Gomes E.A.; Gomes A.A.S.; Siqueira-J&#xFA;nior J.P.; Mendon&#xE7;a Junior F.J.B.; Aminoguanidine hydrazones (AGH\u2019s) as modulators of norfloxacin resistance in Staphylococcus aureus that overexpress NorA efflux pump. Chem Biol Interact 2018,280,8-14","journal-title":"Chem Biol Interact"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1021\/acschemneuro.8b00099","volume":"9","author":"Hammoud H.","year":"2018","unstructured":"Hammoud H.; Elhabazi K.; Quillet R.; Bertin I.; Utard V.; Laboureyras E.; Bourguignon J-J.; Bihel F.; Simonnet G.; Simonin F.; Schmitt M.; Aminoguanidine hydrazone derivatives as nonpeptide NPFF1 receptor antagonists reverse opioid induced hyperalgesia. ACS Chem Neurosci 2018,9(11),2599-2609","journal-title":"ACS Chem Neurosci"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ejmech.2016.03.078","volume":"117","author":"Pape V.F.S.","year":"2016","unstructured":"Pape V.F.S.; T&#xF3;th S.; F&#xFC;redi A.; Szeb&#xE9;nyi K.; Lovrics A.; Szab&#xF3; P.; Wiese M.; Szak&#xE1;cs G.; Design, synthesis and biological evaluation of thiosemicarbazones, hydrazinobenzothiazoles and arylhydrazones as anticancer agents with a potential to overcome multidrug resistance. Eur J Med Chem 2016,117,335-354","journal-title":"Eur J Med Chem"},{"key":"ref=53","first-page":"535","volume":"52B","author":"Patel H.D.","year":"2013","unstructured":"Patel H.D.; Divatia S.M.; Clercq E.; Synthesis of some novel thiosemicarbazone derivatives having anti-cancer, Anti-HIV as well as anti-bacterial activity. Indian J Chem 2013,52B,535-545","journal-title":"Indian J Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejmech.2015.05.046","volume":"100","author":"Alves M.A.","year":"2015","unstructured":"Alves M.A.; de Queiroz A.C.; Alexandre-Moreira M.S.; Varela J.; Cerecetto H.; Gonz&#xE1;lez M.; Doriguetto A.C.; Landre I.M.; Barreiro E.J.; Lima L.M.; Design, synthesis and in vitro trypanocidal and leishmanicidal activities of novel semicarbazone derivatives. Eur J Med Chem 2015,100,24-33","journal-title":"Eur J Med Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10406638.2019.1686405","author":"Divar M.","year":"2019","unstructured":"Divar M.; Zomorodian K.; Sabet R.; Moeini M.; Khabnadideh S.; An efficient method for synthesis of some novel spirooxindole-4H-pyran derivatives. Polycycl Aromat Compd 2019,1-14","journal-title":"Polycycl Aromat Compd"},{"key":"ref=56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006969","volume":"12","author":"Turcano L.","year":"2018","unstructured":"Turcano L.; Torrente E.; Missineo A.; Andreini M.; Gramiccia M.; Di Muccio T.; Genovese I.; Fiorillo A.; Harper S.; Bresciani A.; Colotti G.; Ilari A.; Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening. PLoS Negl Trop Dis 2018,12(11)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.2174\/0929867033456963","volume":"10","author":"Chibale K.","year":"2003","unstructured":"Chibale K.; Musonda C.C.; The synthesis of parasitic cysteine protease and trypanothione reductase inhibitors. Curr Med Chem 2003,10(18),1863-1889","journal-title":"Curr Med Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ejmech.2017.01.022","volume":"127","author":"Romero A.H.","year":"2017","unstructured":"Romero A.H.; Medina R.; Alcala A.; Garc&#xED;a-Marchan Y.; N&#xFA;&#xF1;ez-Duran J.; Lea&#xF1;ez J.; Mijoba A.; Ciangherotti C.; Serrano-Mart&#xED;n X.; L&#xF3;pez S.E.; Design, synthesis, structure-activity relationship and mechanism of action studies of a series of 4-chloro-1-phthalazinyl hydrazones as a potent agent against Leishmania braziliensis. Eur J Med Chem 2017,127,606-620","journal-title":"Eur J Med Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bioorg.2017.03.008","volume":"72","author":"Romero A.H.","year":"2017","unstructured":"Romero A.H.; Rodr&#xED;guez J.; Garc&#xED;a-Marchan Y.; Lea&#xF1;ez J.; Serrano-Mart&#xED;n X.; L&#xF3;pez S.E.; Aryl- or heteroaryl-based hydrazinylphthalazine derivatives as new potential antitrypanosomal agents. Bioorg Chem 2017,72,51-56","journal-title":"Bioorg Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1021\/ml200280r","volume":"3","author":"Verma R.K.","year":"2012","unstructured":"Verma R.K.; Prajapati V.K.; Verma G.K.; Chakraborty D.; Sundar S.; Rai M.; Dubey V.K.; Singh M.S.; Molecular docking and in vitro antileishmanial evaluation of chromene-2-thione Analogues. ACS Med Chem Lett 2012,3(3),243-247","journal-title":"ACS Med Chem Lett"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406417666210216154428","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/191478\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406417666210216154428","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T12:05:08Z","timestamp":1652184308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/191478\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406417666210216154428","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-06-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}